Inventaire - your friends and communities are your best library

The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD

Author

Nicola A Hanania

Published in: International Journal of Chronic Obstructive Pulmonary Disease

Date of publication: January 1, 2006

Language: English

Main subject: chronic obstructive pulmonary disease, mechanism of action, airway obstruction, hormone

Bibliographic databases:

Cites articles 56

Date

Title

Authors

March 1, 1992

Measuring compliance with inhaled medication in asthma
October 1, 1994

Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro
July 1, 1995

Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo
February 1, 1997

Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa
May 1, 1997

Corticosteroid reversibility in COPD is related to features of asthma
January 1, 1999

Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells
August 1, 1999

Effect of fluticasone propionate and salmeterol on Pseudomonas aeruginosa infection of the respiratory mucosa in vitro
January 1, 2000

Improving patient compliance with asthma therapy
June 1, 2000

Type 1 cytokines and the pathogenesis of tuberculosis
February 1, 2000

Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease
July 1, 2000

Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells
February 1, 2000

Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease
June 1, 2001

Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells
September 1, 2001

Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease
January 1, 2001

Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids
November 1, 2001

Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease

,
October 1, 2002

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
July 1, 2002

The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials
September 5, 2002

Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study

,
October 1, 2002

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease
May 2, 2003

Beta-adrenergic agonists inhibit corticosteroid-induced apoptosis of airway epithelial cells,β-Adrenergic agonists inhibit corticosteroid-induced apoptosis of airway epithelial cells
December 1, 2003

Longitudinal changes in the nature, severity and frequency of COPD exacerbations
December 1, 2003

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease
December 1, 2003

Combination therapy for chronic obstructive pulmonary disease: one size fits all?
September 1, 2003

The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.
February 1, 2003

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
January 1, 2003

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease
January 1, 2003

Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations
November 1, 2003

Respiratory failure in chronic obstructive pulmonary disease
December 1, 2004

Patient-centred outcomes in primary care management of COPD - what do recent clinical trial data tell us?
January 1, 2004

Corticosteroid resistance in airway disease
January 1, 2004

Reducing the frequency and severity of exacerbations of chronic obstructive pulmonary disease

Article -

Welcome to inventaire

The library of your friends and communities

Learn more